Predictors of Developing Hepatocellular Carcinoma in Treated HCV-Carriers in Morocco according to University Hospital Experience

Table 3

Fibrosis is significantly associated to HCC occurrence in sustained virological responders ****.

	Patients with developed HCC		Patients with no HCC	𝑃
Gender
Male	3.3%	Versus	96.7%	𝑃=1
Female	3.4%	Versus	96.6%
Age of diagnosis
Age ≤ 55	1%	Versus	99%	𝑃=0.1
Age > 55	5.7%	Versus	94.3%
HCV Genotypes
1	1.3%	Versus	98.7%	𝑃=0.4
2	4.7%	Versus	95.3%
Baseline viral loads (BVL)
High BVL	3%	Versus	97%	𝑃=0.57
Low BVL	1.1%	Versus	98.9%
Necroinflammatory activity
𝐴≤2	3.2%	Versus	96.8%	𝑃=0.4
𝐴>2	6.3%	Versus	93.7%
Fibrosis****
𝐹≤2	0%	Versus	100%	𝑃=0.01
𝐹>2	8.8%	Versus	91.2%